HIV, HCV and overdose prevention for Human Immunodeficiency Virus Infection

Phase-Based Progress Estimates
Lighthouse Studies at Peer Point, Baltimore, MDHuman Immunodeficiency Virus Infection+2 MoreHIV, HCV and overdose prevention - Behavioral
All Sexes
What conditions do you have?

Study Summary

This trial is testing whether a targeted, peer-driven intervention can reduce HIV and HCV transmission, as well as overdose risk behaviors, among people who inject drugs.

Eligible Conditions
  • Human Immunodeficiency Virus (HIV) Infection
  • Drug Overdose
  • Hepatitis C

Treatment Effectiveness

Study Objectives

2 Primary · 2 Secondary · Reporting Duration: 6 months

6 months
HIV/HCV prevention
Overdose behaviors
Overdose behaviors 2
Overdose prevention

Trial Safety

Trial Design

2 Treatment Groups

1 of 2
1 of 2

Active Control

Experimental Treatment

285 Total Participants · 2 Treatment Groups

Primary Treatment: HIV, HCV and overdose prevention · No Placebo Group · N/A

Experimental Group · 1 Intervention: HIV, HCV and overdose prevention · Intervention Types: Behavioral
ActiveComparator Group · 1 Intervention: HIV, HCV and overdose prevention · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 6 months

Who is running the clinical trial?

Johns Hopkins Bloomberg School of Public HealthLead Sponsor
371 Previous Clinical Trials
1,946,239 Total Patients Enrolled
Carl Latkin, PhDPrincipal InvestigatorJohns Hopkins Bloomberg School of Public Health
4 Previous Clinical Trials
3,442 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Who else is applying?

What state do they live in?
How old are they?
What site did they apply to?
Lighthouse Studies at Peer Point100.0%
What portion of applicants met pre-screening criteria?
Did not meet criteria100.0%

Frequently Asked Questions

Are there still openings for participation in this clinical trial?

"Affirmative. The details on confirm that the trial, initially posted April 30th 2022, is presently enrolling participants. About 285 individuals must be recruited from a single medical centre." - Anonymous Online Contributor

Unverified Answer

How many participants are eligible to take part in this clinical research?

"Affirmative. Per information accessible on, this study is currently looking for participants to enrol. The trial was first posted April 30th 2022 and most recently updated September 7th 2022; the research seeks 285 volunteers from a single location." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.